News
SenesTech and ContraPest® Featured at the Animal Care Expo in New Orleans
Growth in the Animal Care Segment of Pest Control Continues to Be Strong PHOENIX, April 11, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered...
TIME Magazine Takes a Closer Look at ContraPest as a Solution to Global Rat Infestations
PHOENIX, March 29, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, were featured in TIME...
SenesTech Announces 2022 Financial Results
Product Sales Break $1 Million Sales Increase 77% for the Year PHOENIX, March 16, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA-registered contraceptive for...
ContraPest® Success Stories Reported at Vertebrate Pest Conference
PHOENIX, Feb. 28, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced that...
SenesTech Names Nicole Williams as Chief Revenue Officer
PHOENIX, Feb. 16, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today reported the...
SenesTech to Participate in the Lytham Partners Investor Select Conference
PHOENIX, Jan. 24, 2023 -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today announced the management team will present and host one-on-one meetings with investors at...
SenesTech Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PHOENIX, Dec. 20, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today reported the grant...
SenesTech, Inc. Announces Closing of $5 Million Public Offering
PHOENIX, Nov. 18, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company") (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced the...
SenesTech, Inc. Announces Pricing of $5 Million Public Offering
PHOENIX, Nov. 16, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company") (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced the...
SenesTech Announces Reverse Stock Split
Common Stock Will Begin Trading on a Split-Adjusted Basis on November 16, 2022 PHOENIX, Nov. 15, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company") (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered...